Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-24

Clinical Trial Update: Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 1 g vs 2 g per hour IV maintenance dose of magnesium sulfate in women with severe pre-eclampsia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Assiut University | Conditions: Severe Preeclampsia | Phase 4 | Status: COMPLETED